Home/Filings/4/0001140361-17-008616
4//SEC Filing

VASCULAR SOLUTIONS INC 4

Accession 0001140361-17-008616

CIK 0001030206operating

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 4:28 PM ET

Size

19.8 KB

Accession

0001140361-17-008616

Insider Transaction Report

Form 4
Period: 2017-02-17
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-02-17$46.39/sh10,000$463,9000 total
    Exercise: $9.61Exp: 2020-04-22Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-02-17$44.37/sh10,000$443,7000 total
    Exercise: $11.63Exp: 2022-05-04Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-02-17$49.64/sh10,000$496,4000 total
    Exercise: $6.36Exp: 2018-04-22Common Stock (10,000 underlying)
  • Disposition to Issuer

    Common Stock

    2017-02-1761,2280 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-02-17$46.59/sh10,000$465,9000 total
    Exercise: $9.41Exp: 2017-04-24Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-02-17$49.61/sh10,000$496,1000 total
    Exercise: $6.39Exp: 2019-04-21Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-02-17$44.28/sh10,000$442,8000 total
    Exercise: $11.72Exp: 2021-04-22Common Stock (10,000 underlying)
Holdings
  • Common Stock

    61,228
Footnotes (7)
  • [F1]In connection with the merger of Issuer and a subsidiary of Teleflex Incorporated (the "Merger") pursuant to an agreement and plan of merger dated December 1, 2016, all shares of Issuer common stock were canceled and automatically converted into the right to receive $56.00 per share in cash, without interest and less any applicable withholding taxes.
  • [F2]This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $465,900, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option.
  • [F3]This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $496,400, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option.
  • [F4]This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $496,100, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option.
  • [F5]This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $463,900, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option.
  • [F6]This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $442,800, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option.
  • [F7]This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $443,700, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option.

Documents

1 file

Issuer

VASCULAR SOLUTIONS INC

CIK 0001030206

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0001030206

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:28 PM ET
Size
19.8 KB